Impact of educational print materials on knowledge, attitudes, and interest in BRCA1/BRCA2
CancerPublished 1 January 2001Open access
Marc D. Schwartz, Judith Benkendorf, Caryn Lerman, Claudine Isaacs, Anna Ryan-Robertson, Lenora Johnson
Citations94
SJR quartileQ1
SJR score2.95
SNIP1.90
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Whether a brief educational booklet regarding BRCA1/BRCA2 testing would influence knowledge, attitudes, and interest in testing among Ashkenazi Jewish women from the general population is examined.
Abstract
These data indicate that preliminary print education can be used to educate low-risk individuals about BRCA1/BRCA2 genetic testing. This approach may be used to educate low-risk individuals about the benefits and risks/limitations of BRCA1/BRCA2 testing, so that they can make informed decisions about whether to pursue genetic counseling.
Keywords
Biochemistry, Genetics and Molecular Biology
The American Journal of Human GeneticsGenetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families
3,047 Citations1998Deborah Ford, Douglas F. Easton +36 more
The lifetime risk of breast cancer appears similar to the risk in BRCA1 carriers, but there was some suggestion of a lower risk in bRCA2 carriers <50 years of age.
New England Journal of MedicineThe Risk of Cancer Associated with Specific Mutations of<i>BRCA1</i>and<i>BRCA2</i>among Ashkenazi Jews
2,262 Citations1997Jeffery P. Struewing, Patricia Hartge +7 more
The risks of breast cancer may be overestimated, but they fall well below previous estimates based on subjects from high-risk families.
The LancetRisks of cancer in BRCA1-mutation carriers
1,866 Citations1994Daniel Ford
Estimates of breast and ovarian cancer risks are provided which are useful for counselling BRCA1-mutation carriers and carriers are at increased risk of colon and prostate cancer, which may be of clinical significance in certain families if the risks are associated with specific mutations.
PubMedGenetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.
1,253 Citations1993Douglas F. Easton, D. Timothy Bishop +2 more
The results suggest that a gene(s) on chromosome 17q accounts for the majority of families in which both early-onset breast cancer and ovarian cancer occur but that other genes predisposing to breast cancer exist.
Nature GeneticsAshkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2
776 Citations1996Benjamin B. Roa, Alfred A. Boyd +2 more
This expanded population-based study confirms that the BRCA1 185delAG mutation and theBRCA2 6174delT mutation constitute the two most frequent mutation alleles predisposing to hereditary breast cancer among the Ashkenazim, and suggests a relatively lower penetrance for the 6174DelT mutation in BRCa2.
New England Journal of Medicine<i>BRCA1</i>Mutations in Women Attending Clinics That Evaluate the Risk of Breast Cancer
681 Citations1997Fergus J. Couch, Michelle L. DeShano +11 more
The results suggest that even in a referral clinic specializing in screening women from high-risk families, the majority of tests for BRCA1 mutations will be negative and therefore uninformative.
PubMedEstimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence.
537 Citations1995D Ford, Douglas F. Easton +1 more
The results suggest that the majority of breast cancer families with less than four cases and no ovarian cancer are not due to rare highly penetrant genes such as BRCA1 but are more likely to be due either to chance or to more common genes of lower penetrance.
Journal of Clinical OncologyAttitudes about genetic testing for breast-ovarian cancer susceptibility.
525 Citations1994Caryn Lerman, Mary B. Daly +2 more
The results suggest that the demand for genetic testing for BRCA1 among FDRs of cancer patients may be great, and those who elect to participate may represent a more psychologically vulnerable subgroup of high-risk women.
New England Journal of MedicineGerm-Line<i>BRCA1</i>Mutations in Jewish and Non-Jewish Women with Early-Onset Breast Cancer
388 Citations1996Michael G. FitzGerald, Deborah J. MacDonald +17 more
JNCI Journal of the National Cancer InstituteControlled Trial of Pretest Education Approaches to Enhance Informed Decision-Making for BRCA1 Gene Testing
354 Citations1997Caryn Lerman, Jon Kerner +5 more
Standard educational approaches may be equally effective as expanded counseling approaches in enhancing knowledge and standard education may be adequate in situations where genetic testing must be streamlined.
Journal of Consulting and Clinical PsychologyThe influence of psychological distress on use of genetic testing for cancer risk.
178 Citations1997Caryn Lerman, Mark D. Schwartz +3 more
Examination of the relationships between psychological distress and use of BRCA1 testing by 149 high-risk individuals from hereditary cancer families found cancer-specific distress was significantly and positively related to BRCa1 test use, whereas global distress was unrelated to test use.
American Journal of Public HealthWomen's receptivity to testing for a genetic susceptibility to breast cancer.
173 Citations1995Hari P. Chaliki, Starlene Loader +4 more
Patients undergoing mammography and visiting their obstetrician-gynecologist were asked whether they would take a breast cancer 1 (BRCA1) test to detect a genetic susceptibility to breast cancer, and if shown to have inherited a susceptibility, many reported that they would be very anxious, would want the test repeated, and would want mammography more often than yearly.
Psychosomatic MedicineDecision-Making About Genetic Testing Among Women at Familial Risk for Breast Cancer
168 Citations1997Paul B. Jacobsen, Heiðdís Valdimarsdóttir +2 more
The readiness of many women to seek breast cancer susceptibility testing can be attributed to their perceptions that the advantages outweigh the disadvantages, and examination of these perceptions suggests that notification of carrier status may have significant effects on women's psychological well-being and breast cancer surveillance and prevention behaviors.
American Journal of Medical GeneticsGenetic testing for breast cancer susceptibility: Awareness and interest among women in the general population
151 Citations1997Ellen Tambor, Barbara K. Rimer +1 more
The extent to which a group of female HMO enrollees were aware of the discovery of the BRCA1 gene and whether they would be interested in being tested to find out if they have the gene was examined to have implications for education and counseling.
Preventive MedicineInterest in Genetic Testing for Colon Cancer Susceptibility: Cognitive and Emotional Correlates
141 Citations1993Robert T. Croyle, Caryn Lerman
These results show a high level of public interest in genetic testing for colon cancer susceptibility and suggest that anxiety does not undermine interest, but future research must determine whether this relationship is limited to hypothetical judgments such as those studied here.
New England Journal of MedicinePitfalls of Genetic Testing
95 Citations1996R. Glenn Hubbard, Richard C Lewontin
Genes have become the preferred way to explain all types of ill health and unwanted behavior, but some of the attributions seem fairly clear-cut, but many are being embraced uncritically and oversold.
American Journal of Medical GeneticsGenetic counseling for women with an intermediate family history of breast cancer
85 Citations2000Wylie Burke, Julie O. Culver +5 more
It is concluded that genetic counseling can help women with an intermediate family history of breast cancer to develop more accurate views of their risk, reduce their breast cancer worry, and aid some of them in developing a more realistic view of genetic testing.
American Journal of Preventive MedicineBRCA1 and BRCA2 gene mutations and risk of breast cancer:
48 Citations1999Steven S. Coughlin, Muin J. Khoury +1 more
Due to the proliferation of laboratories offering genetic tests for breast cancer susceptibility, their appropriate use in public health needs careful scrutiny and several issues are raised when such genetic tests are considered for population-based prevention programs for Breast cancer.